Ad-FP

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NameAd-FP
Drug Alias Namerecombinant adenovirus (Sichuan University/Zhongheng Group)
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vector
Mechanisms of ActionFibroblast growth factor 2 modulatorsPlatelet-derived growth factor subunit B modulators
TargetsFibroblast growth factor 2Platelet-derived growth factor subunit B
Therapy Area/IndicationsMyocardial IschemiaPeripheral arterial occlusive disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesSichuan University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGuangxi Wuzhou Zhongheng Group Co LtdSichuan University
Active IndicationsN/A
Inactive IndicationsMyocardial IschemiaPeripheral arterial occlusive disorders

Other Information

ATC CodeN/A
Related LinksN/A